Potential effects of the new medicare drug benefit on pricing for psychotropic medicationsHUSKAMP, Haiden A; SHINOGLE, Judith A.Psychiatric services (Washington, D.C.). 2005, Vol 56, Num 9, pp 1056-1058, issn 1075-2730, 3 p.Article

Diffusion of Antipsychotics in the U.S. and French Markets, 1998―2008GALLINI, Adeline; DONOHUE, Julie M; HUSKAMP, Haiden A et al.Psychiatric services (Washington, D.C.). 2013, Vol 64, Num 7, pp 680-687, issn 1075-2730, 8 p.Article

Moving beyond Parity — Mental Health and Addiction Care under the ACABARRY, Colleen L; HUSKAMP, Haiden A.The New England journal of medicine. 2011, Vol 365, Num 11, pp 973-975, issn 0028-4793, 3 p.Article

The new medicare drug benefit : Formularies and their potential effects on access to medicationsHUSKAMP, Haiden A; KEATING, Nancy L.Journal of general internal medicine. 2005, Vol 20, Num 7, pp 662-665, issn 0884-8734, 4 p.Article

Behavioral health services under medicaid managed care : The uncertain implications of state variationHANSON, Kristina W; HUSKAMP, Haiden A.Psychiatric services (Washington, D.C.). 2001, Vol 52, Num 4, pp 447-450, issn 1075-2730Article

Implementation of Medicare Part D and Nondrug Medical Spending for Elderly Adults With Limited Prior Drug CoverageMCWILLIAMS, J. Michael; ZASLAVSKY, Alan M; HUSKAMP, Haiden A et al.JAMA, the journal of the American Medical Association. 2011, Vol 306, Num 4, pp 402-409, issn 0098-7484, 8 p.Article

Aligning incentives in the treatment of depression in primary care with evidence-based practiceFRANK, Richard G; HUSKAMP, Haiden A; PINCUS, Harold Alan et al.Psychiatric services (Washington, D.C.). 2003, Vol 54, Num 5, pp 682-687, issn 1075-2730, 6 p.Article

A Political History of Federal Mental Health and Addiction Insurance ParityBARRY, Colleen L; HUSKAMP, Haiden A; GOLDMAN, Howard H et al.The Milbank quarterly. 2010, Vol 88, Num 3, pp 404-433, issn 0887-378X, 30 p.Article

Generic Entry, Reformulations and Promotion of SSRIs in the USHUSKAMP, Haiden A; DONOHUE, Julie M; KOSS, Catherine et al.PharmacoEconomics (Auckland). 2008, Vol 26, Num 7, pp 603-616, issn 1170-7690, 14 p.Article

The impact of withdrawals by medicaid managed care plans on behavioral health servicesHUSKAMP, Haiden A; GARNICK, Deborah W; HANSON, Kristina W et al.Psychiatric services (Washington, D.C.). 2001, Vol 52, Num 5, pp 600-602, issn 1075-2730Article

Medicare Part D and nursing home residentsSTEVENSON, David G; HUSKAMP, Haiden A; KEATING, Nancy L et al.Journal of the American Geriatrics Society. 2007, Vol 55, Num 7, pp 1115-1125, issn 0002-8614, 11 p.Article

Angiotensin receptor blockers on the formularies of medicare drug plansGELLAD, Walid F; HUSKAMP, Haiden A; PHILLIPS, Kathryn A et al.Journal of general internal medicine. 2007, Vol 22, Num 8, pp 1172-1175, issn 0884-8734, 4 p.Article

Characteristics of Adults With Substance Use Disorders Expected to Be Eligible for Medicaid Under the ACABUSCH, Susan H; MEARA, Ellen; HUSKAMP, Haiden A et al.Psychiatric services (Washington, D.C.). 2013, Vol 64, Num 6, pp 520-526, issn 1075-2730, 7 p.Article

Physical and mental health status of older long-term cancer survivorsKEATING, Nancy L; NØRREDAM, Marie; LANDRUM, Mary Beth et al.Journal of the American Geriatrics Society. 2005, Vol 53, Num 12, pp 2145-2152, issn 0002-8614, 8 p.Article

The effect of incentive-based formularies on prescription-drug utilization and spendingHUSKAMP, Haiden A; DEVERKA, Patricia A; EPSTEIN, Arnold M et al.The New England journal of medicine. 2003, Vol 349, Num 23, pp 2224-2232, issn 0028-4793, 9 p.Article

Changes in Physician Antipsychotic Prescribing Preferences, 2002―2007DONOHUE, Julie; O'MALLEY, A. James; HORVITZ-LENNON, Marcela et al.Psychiatric services (Washington, D.C.). 2014, Vol 65, Num 3, pp 315-322, issn 1075-2730, 8 p.Article

Part D and Dually Eligible Patients With Mental Illness: Medication Access Problems and Use of Intensive ServicesHUSKAMP, Haiden A; WEST, Joyce C; RAE, Donald S et al.Psychiatric services (Washington, D.C.). 2009, Vol 60, Num 9, pp 1169-1174, issn 1075-2730, 6 p.Article

Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004―2010DUSETZINA, Stacie B; CALEB ALEXANDER, G; FREEDMAN, Rachel A et al.Breast cancer research and treatment. 2013, Vol 137, Num 1, pp 285-296, issn 0167-6806, 12 p.Article

Beneficiaries With Cardiovascular Disease and the Part D Coverage GapPOLINSKI, Jennifer M; SHRANK, William H; GLYNN, Robert J et al.Circulation. Cardiovascular quality and outcomes (Print). 2012, Vol 5, Num 3, pp 387-395, issn 1941-7713, 9 p.Article

Use of Prescription Drug Samples and Patient Assistance Programs, and the Role of Doctor-Patient CommunicationGELLAD, Walid F; HUSKAMP, Haiden A; LI, Angela et al.Journal of general internal medicine. 2011, Vol 26, Num 12, pp 1458-1464, issn 0884-8734, 7 p.Article

How Quickly Do Physicians Adopt New Drugs? The Case of Second-Generation AntipsychoticsHUSKAMP, Haiden A; O'MALLEY, A. James; HORVITZ-LENNON, Marcela et al.Psychiatric services (Washington, D.C.). 2013, Vol 64, Num 4, pp 324-330, issn 1075-2730, 7 p.Article

Racial and Ethnic Disparities in Postpartum Depression Care Among Low-Income WomenBACKES KOZHIMANNIL, Katy; MAH TRINACTY, Connie; BUSCH, Alisa B et al.Psychiatric services (Washington, D.C.). 2011, Vol 62, Num 6, pp 619-625, issn 1075-2730, 7 p.Article

Coverage and prior authorization of psychotropic drugs under medicare part DHUSKAMP, Haiden A; STEVENSON, David G; DONOHUE, Julie M et al.Psychiatric services (Washington, D.C.). 2007, Vol 58, Num 3, pp 308-310, issn 1075-2730, 3 p.Article

Racial-Ethnic Differences in Incident Olanzapine Use After an FDA Advisory for Patients With SchizophreniaDUSETZINA, Stacie B; COOK, Benjamin L; BUSCH, Alisa B et al.Psychiatric services (Washington, D.C.). 2013, Vol 64, Num 1, pp 83-87, issn 1075-2730, 5 p.Article

Association Between the Part D Coverage Gap and Adverse Health OutcomesPOLINSKI, Jennifer M; SHRANK, William H; GLYNN, Robert J et al.Journal of the American Geriatrics Society. 2012, Vol 60, Num 8, pp 1408-1417, issn 0002-8614, 10 p.Article